CPC Exam Dumps - Certified Professional Coder (CPC) Exam

1. E/M Service Code Selection:

On day two, the urologist provided an evaluation and management (E/M) service for a hospitalized patient with a low level for the number and complexity of problems addressed, minimal complexity for data reviewed, and moderate risk of complications.

CPT® Code 99232 is for a subsequent hospital care E/M service with a level of "Expanded Problem Focused" history and examination, with Medical Decision Making (MDM) of Moderate complexity. This matches the description provided, as the MDM includes a low number of problems, minimal data, and moderate risk.

2. Rationale for Excluding Other Options:

Code 99233 is for a subsequent hospital care visit with high complexity MDM (e.g., addressing a high number of problems or higher levels of data review), which does not align with the moderate risk described here.

Code 99221 is for initial hospital care, not a subsequent visit.

Code 99231 represents a lower level of subsequent hospital care with straightforward or low complexity MDM, which does not meet the moderate risk criteria in this scenario.

3. AAPC and CPT® Coding Guidelines:

AAPC and CPT® guidelines indicate 99232 as appropriate for subsequent hospital visits with moderate MDM, such as this visit with moderate risk but minimal data complexity.

Therefore, the correct answer is B. 99232.

Omalizumab is a drug reported withHCPCS J2357, and the dose is converted into billable units based on the code’s unit definition. In CPC-style questions,150 mgis commonly represented asJ2357 × 30 units(i.e., 5 mg per unit → 150/5 = 30). Administration is atherapeutic subcutaneous injection, reported with96372(therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular). Vaccine administration codes (90460/90471) are not appropriate because omalizumab is not a vaccine. For diagnosis, the statement includesstatus asthmaticusbut does not specify severity category (mild/moderate/severe persistent). In the options provided,J45.902is the “unspecified asthma with status asthmaticus” concept, whereas J45.52 requires severe persistent asthma with status asthmaticus (not documented). Therefore, the correct pairing is96372 + J2357 × 30 + J45.902. CPC exam tip: match administration code type (therapeutic injection vs immunization) and choose the most specific ICD-10-CM supported by documentation.

Procedure Coding:

56633 – Radical vulvectomy (removal of >80%), including deep subcutaneous tissue

Documentation supports greater than 80% vulvar removal

Deep tissue involvement confirms radical procedure

Diagnosis Coding:

D07.1 – Carcinoma in situ of vulva

VIN III = high-grade squamous intraepithelial lesion

Classified as carcinoma in situ, not benign dysplasia

Why Other Options Are Incorrect:

56620 / 56625 / 56630 – Partial or simple vulvectomy

N90.1 – Mild vulvar dysplasia (incorrect severity)

ICD-10-CM Official Guideline:

VIN III is coded as D07.1, not N90.x.

60220 = Total lobectomy, unilateral thyroid

60500 = Parathyroidectomy (single gland)

Modifier -59 is appropriate to indicate a distinct procedure

In ICD-10-CM coding, personal history codes are used to indicate a patient’s past medical conditions that no longer exist and are not receiving active treatment, but that may influence current care or require continued monitoring.

A. is correct because a personal history code can indeed be reported as a primary code if the encounter is specifically for screening due to a past condition.

B. is correct because personal history codes can be reported with follow-up codes to indicate that the patient is being monitored for recurrence of the past condition.

D. is correct because a personal history code is used when the patient no longer has or is being treated for that condition, but it remains relevant to the patient’s health history.

C. is false because a personal history code is not used indiscriminately on any medical record; it is only appropriate when the past condition is relevant to the current encounter or impacts current patient care.

Therefore, the correct answer is C. A personal history code is acceptable on any medical record regardless of the reason of the visit.

To accurately code a pressure ulcer in ICD-10-CM, the code must reflect the ulcer's location and stage. The codes for pressure ulcers specify both the anatomical site and the stage (extent of tissue damage).

L89.613 represents a pressure ulcer on the right heel at stage 3. The stage is critical as it indicates the severity of the ulcer, with stage 3 involving full-thickness skin loss and possibly visible subcutaneous tissue.

A. L89.609 refers to a pressure ulcer on the heel but without specific staging.

C. L89.619 is for a pressure ulcer on the right heel at stage 4, which indicates a more severe level of tissue damage than stage 3.

D. L89.603 represents a stage 3 pressure ulcer but on the left heel, not the right.

Therefore, the correct answer is B. L89.613 for a stage 3 pressure ulcer on the right heel.

AnExcludes1note means“NOT CODED HERE”and indicates that the two conditionscannot be reported togetherbecause they are eithermutually exclusiveor one condition is inherently included in the other in that context. In practical CPC exam terms, if an Excludes1 note applies between two codes, you generallydo not assign both codes on the same encounter. This is different fromExcludes2, which means the excluded condition isnot part of the code, but the patient may haveboth conditions at the same time, soboth codes may be reportedif supported by documentation. NEC (Not Elsewhere Classifiable) points you to a more specific code when available; NOS (Not Otherwise Specified) reflects insufficient detail in documentation. The question is specifically about a note that prevents reporting two conditions together—this is the hallmark definition ofExcludes1under ICD-10-CM conventions and is heavily tested on CPC exams.

Fascia debridement → 11043 (first 20 sq cm)

Subcutaneous debridement → 11042

Multiple anatomical sites → Modifier -59

Add-on code 11045 for additional subcutaneous surface area